Supraventricular Tachycardia Causing Left Ventricular Dysfunction.

[1]  G. Breithardt,et al.  Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. , 2020, The New England journal of medicine.

[2]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[3]  L. Mestroni,et al.  Contemporary survival trends and aetiological characterization in non‐ischaemic dilated cardiomyopathy , 2020, European journal of heart failure.

[4]  K. Ellenbogen,et al.  Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review. , 2019, Journal of the American College of Cardiology.

[5]  G. Sinagra,et al.  Myocarditis evolving in cardiomyopathy: when genetics and offending causes work together , 2019, European heart journal supplements : journal of the European Society of Cardiology.

[6]  D. O’Regan,et al.  Genetic Etiology for Alcohol-Induced Cardiac Toxicity , 2018, Journal of the American College of Cardiology.

[7]  P. Elliott,et al.  Evolving concepts in dilated cardiomyopathy , 2018, European journal of heart failure.

[8]  Patrizio Lancellotti,et al.  Recommendations for the Evaluation of Left Ventricular Diastolic Function by Echocardiography: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2016, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[9]  J. Seidman,et al.  Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. , 2016, The New England journal of medicine.

[10]  Dhanunjaya R. Lakkireddy,et al.  Arrhythmia-Induced Cardiomyopathies , 2015, Contemporary Cardiology.

[11]  J. Piccini,et al.  Atrial fibrillation in heart failure: what should we do? , 2015, European heart journal.

[12]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[13]  B. Lindsay,et al.  ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, Ameri , 2013, Journal of the American College of Cardiology.

[14]  D. Mukherjee,et al.  Pharmacologic Rate versus Rhythm‐Control Strategies in Atrial Fibrillation: An Updated Comprehensive Review and Meta‐Analysis , 2013, Pacing and clinical electrophysiology : PACE.

[15]  G. Barbati,et al.  Impact of Atrial Fibrillation on Outcome of Patients with Idiopathic Dilated Cardiomyopathy: Data from the Heart Muscle Disease Registry of Trieste , 2010, Clinical Medicine & Research.

[16]  Jong-Min Song,et al.  Diagnostic Approach and Treatment Strategy in Tachycardia‐induced Cardiomyopathy , 2008, Clinical cardiology.

[17]  Qi Jiang,et al.  Illustrating the Impact of a Time-Varying Covariate With an Extended Kaplan-Meier Estimator , 2005 .

[18]  M. Santini,et al.  Atrial fibrillation and heart failure. , 2004, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[19]  B. Olshansky,et al.  Heart Failure and Sudden Death in Patients With Tachycardia-Induced Cardiomyopathy and Recurrent Tachycardia , 2004, Circulation.